Journal of Biomedical Engineering and Medical Devices
Open Access

Note on Advancements in Medical Implants

Pavan Kumar^{* *}Correspondence: Pavan Kumar, Department of Mechanical Engineering, Indian Institute of Technology, Delhi, India, Email:

Author info »

Description

Biomedical devices that can be implanted in the body for drug delivery, tissue designing, or detecting can help with further developing therapy for many disorders. However, such devices are frequently vulnerable to attack by the immune system, which can deliver them. A group of researchers has thought of a method for decreasing that immune-system rejection. They observed that the geometry of implantable devices fundamentally impact how well the body will endure them. Though the specialists expected that smaller devices may be better ready to avoid the immune system, they found that larger spherical devices are better able to maintain their function and avoid scar-tissue development.

They were astonished by how much the size and state of an implant can influence an immune response. The specialists desire to utilize this knowledge for additional development of an implantable device that could mimic the function of the pancreas, possibly offering a long-term treatment for diabetic patients. It could also be applicable to devices which are used to treat numerous disorders.

Implanting cells

This study outgrew the specialists' efforts to build an artificial pancreas, which started several years ago. The objective is to deliver pancreatic islet cells encapsulated within a molecule made of alginate, a polysaccharide naturally found in algae or another material. These implanted cells could replace patients' pancreatic islet cells, which are nonfunctional in Type I diabetes.

Very much like normal islet cells, these cells would detect sugar levels in the blood and secrete the appropriate amount of insulin to absorb the sugar, eliminating the requirement for insulin infusions. In any case, if implanted cells are surrounded by scartissue, they cannot function effectively. The purpose behind these implantable devices is to safeguard the cells from the immune system, yet permit them to remain alive and continue to function.

The scientists tested spheres in two sizes, 0.5 and 1.5 milli-meters in width. In test of diabetic mice, the spheres were implanted inside the abdominal cavity and the analysts followed their ability to precisely respond to changes in glucose levels. The devices prepared with the smaller spheres were totally surrounded by scar tissue and failed after about a month, while the larger ones were not rejected and kept on working for over a half year.

The larger spheres also avoided the immune system in tests in nonhuman primates. Smaller spheres implanted under the skin were engulfed by scar tissue just after 14 days, while the larger ones remained clear for about a month. This impact was seen with alginate, yet in addition with other spheres made of stainless steel, glass, polystyrene, and polycaprolactone, a type of polyester. They realized that regardless of what composition the material is, this impact actually persists, and that made it significantly more exciting since it's much more generalizable.

Size and shape

The scientists believe this finding could be applicable to any other type of implantable device, including drug-delivery vehicles and sensors for glucose and insulin, which could also help improve diabetes treatment. Optimizing molecule size and shape could likewise help scientists in developing different types of implantable cells for treating diseases other than diabetes. For any of these devices that individuals need to make, they should be cautious regarding the size and shape of them.